• Corpus ID: 7691392

Effects of inhibiting cholesterol absorption and synthesis on cholesterol and lipoprotein metabolism in hypercholesterolemic non-insulin-dependent diabetic men.

@article{Gylling1996EffectsOI,
  title={Effects of inhibiting cholesterol absorption and synthesis on cholesterol and lipoprotein metabolism in hypercholesterolemic non-insulin-dependent diabetic men.},
  author={Helena Gylling and Tatu A. Miettinen},
  journal={Journal of lipid research},
  year={1996},
  volume={37 8},
  pages={
          1776-85
        }
}
Effectiveness of a simultaneous inhibition of cholesterol absorption and synthesis, caused by sitostanol ester margarine and pravastatin, was studied to control mild hypercholesterolemia in men with non-insulin-dependent diabetes mellitus (NIDDM) (n = 8). Margarine, 24 g daily, was a basal dietary treatment. Four 7-week intervention periods included margarine, sitostanol (3 g/day) ester margarine, pravastatin (40 mg/day), and sitostanol ester margarine plus pravastatin in a random order… 
Effect of a statin on hepatic apolipoprotein B-100 secretion and plasma campesterol levels in the metabolic syndrome
TLDR
In obesity, atorvastatin inhibits cholesterogenesis but increases intestinal cholesterol absorption, and the increased cholesterol absorption may counteract the inhibitory effect on hepatic VLDL-apoB secretion, but it does not apparently influence enhanced catabolism of VLDB.
Removal of intravenous Intralipid in patients with familial hypercholesterolemia during inhibition of cholesterol absorption and synthesis.
TLDR
Despite the retarded removal of TRL lipids by STA and STE in the statin-treated subjects with FH, improvement of the fasting lipid profile was suggested important in consideration of combination of cholesterol absorption inhibitor with statins even in FH.
Changes in serum level and metabolism of cholesterol with plant stanol esters in postmenopausal women with and without coronary artery disease
TLDR
Plant stanol ester margarine consumption effectively reduced serum cholesterol in postmenopausal women with and without coronary artery disease in short-term and for at least 1 year in the noncoronary group, suggesting that stanol Ester Margarine might be used in the long-term for cholesterol lowering in women.
Plant stanol esters lower LDL cholesterol level in statin-treated subjects with type 1 diabetes by interfering the absorption and synthesis of cholesterol.
TLDR
STAEST significantly decreased serum total, LDL and non-HDL cholesterol concentrations and thus offers an additional benefit to cholesterol lowering in patients with type 1 diabetes who are on statin treatment.
Cholesterol Absorption, Synthesis, and Fecal Output in Postmenopausal Women With and Without Coronary Artery Disease
TLDR
The presence of CAD in postmenopausal women is independently associated with altered cholesterol metabolism, as reflected by low synthesis and inefficient elimination of cholesterol.
Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients: relation to basal serum cholestanol.
Coronary patients with low baseline ratios of serum cholestanol and plant sterols to cholesterol (indicating low cholesterol absorption) but not those with high ratios (high absorption) experienced
Plant sterols are efficacious in lowering plasma LDL and non-HDL cholesterol in hypercholesterolemic type 2 diabetic and nondiabetic persons.
TLDR
It is shown that plant sterols are efficacious in lowering LDL cholesterol and non-HDL cholesterol in both diabetic and nondiabetic persons and may exist as a dietary management strategy for hypercholesterolemia in persons with type 2 diabetes.
Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine: women and dietary sitostanol.
TLDR
Dietary use of sitostanol ester margarine normalizes LDL cholesterol in about one third of women with previous myocardial infarction, especially in those with high baseline absorption and low synthesis of cholesterol, and in combination with statins reduces the needed drug dose.
Short-term LDL cholesterol-lowering efficacy of plant stanol esters
TLDR
The specific effect of plant stanol esters on serum LDL cholesterol can fully be obtained within 1–2 weeks of the use of plantStanol ester-enriched margarine.
Effects of ezetimibe on plasma lipoproteins in severely hypercholesterolemic patients treated with regular LDL-apheresis and statins.
TLDR
In patients with severe LDL-hypercholesterolemia and CHD the addition of ezetimibe to intensive lipid lowering therapy (statins and LDL-apheresis) resulted in a further, clinically significant decrease of LDL-cholesterol.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 49 REFERENCES
Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man.
TLDR
Serum lipids, and absorption, intestinal fluxes, fecal elimination, and synthesis of cholesterol were studied before and during 4 weeks of pravastatin treatment, suggesting that cholesterol synthesis was reduced shortly after the start of treatment.
Hypercholesterolemia in non-insulin-dependent diabetes mellitus: different effect of simvastatin on VLDL and LDL cholesterol levels.
TLDR
Simvastatin results indicate that the VLDL are primarily concerned when statins are administered in NIDDM, indicates that the HMG-CoA reductase inhibitors significantly lower cholesterol rates and have an indirect effect on the LDL receptor.
Cholesterol absorption and synthesis during pravastatin, gemfibrozil and their combination.
TLDR
Serum precursor sterols reflected changes in cholesterol synthesis more sensitively than the sterol balance technique, even though only the latter method can quantitate cholesterol synthesis.
Long-term treatment of hypercholesterolemic non-insulin dependent diabetics (NIDDM) with pravastatin (CS-514).
TLDR
The effect of pravastatin on LDL-cholesterol in NIDDM was slower and weaker than that published for non-diabetic hypercholesterolemia, therefore, the mechanism by which pravastsatin suppresses plasma cholesterol levels in these two conditions may differ.
Non-cholesterol sterols and faecal elimination of cholesterol during statin and fibrate treatment
Abstract A simvastatin-induced lowering of low density lipoprotein (LDL)-cholesterol levels was associated with persistent reductions in the proportions of serum precursor sterol ( Δ 8 -cholestanol,
Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
TLDR
Inhibitors of the rate-limiting enzyme of cholesterol biosynthesis, 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase, are now used frequently to treat hypercholesterolemia and results in an increased expression of hepatic LDL receptors, which explains the lowered plasma levels of LDL cholesterol.
Pravastatin therapy in primary moderate hypercholesterolaemia: changes in metabolism of apolipoprotein B‐containing lipoproteins
TLDR
Pravastatin seemingly reduced input rates for all apo B‐containing lipoproteins, consistent with previous studies, this response was most likely the result of enhanced removal of nascent lipoproteinins by increased activity of LDL receptors, although decreased synthesis of apO B in the liver is a possible second action.
Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus.
TLDR
The beneficial effects of lovastatin on plasma lipid levels in patients with NIDDM could decrease the risk of the development of coronary heart disease.
Effects of ketoconazole on cholesterol precursors and low density lipoprotein kinetics in hypercholesterolemia.
TLDR
Ketoconazole, an inhibitor of cholesterol synthesis at 14 alpha-demethylation of lanosterol, effectively reduces serum total and low density lipoprotein (LDL) cholesterol levels and kinetics of LDL apolipoprotein B (apoB) in seven patients with heterozygous familial hypercholesterolemia and in three patients with primary hypercholesterololemia are studied.
Long-term treatment with simvastatin in hypercholesterolemic non-insulin-dependent diabetic patients
TLDR
Simvastatin appears to be an effective and safe hypocholesterolemic drug in patients with non-insulin-dependent diabetes mellitus.
...
1
2
3
4
5
...